Abstract
Although activation of the renin-angiotensin system (RAS) is known to produce ventricular remodeling and congestive heart failure (CHF), its role in inducing changes in the sarcoplasmic reticulum (SR) protein and gene expression in CHF is not fully understood. In this study, CHF was induced in rats by ligation of the left coronary artery for 3 weeks and then the animals were treated orally with or without an angiotensin converting enzyme inhibitor, enalapril (10 mg/kg/day) or an angiotensin II receptor antagonist, losartan (20 mg/kg/day) for 4 weeks. Sham-operated animals were used as control. The animals were hemodynamically assessed and protein content as well as gene expression of SR Ca2+-release channel (ryanodine receptor, RYR), Ca2+-pump ATPase (SERCA2), phospholamban (PLB) and calsequestrin (CQS) were determined in the left ventricle (LV). The infarcted animals showed cardiac hypertrophy, lung congestion, depression in LV +dP/dt and −dP/dt, as well as increase in LV end diastolic pressure. Both protein content and mRNA levels for RYR, SERCA2 and PLB were decreased without any changes in CQS in the failing heart. These alterations in LV function as well as SR protein and gene expression in CHF were partially prevented by treatment with enalapril or losartan. The results suggest that partial improvement in LV function by enalapril and losartan treatments may be due to partial prevention of changes in SR protein and gene expression in CHF and that these effects may be due to blockade of the RAS.
Similar content being viewed by others
References
Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP: Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85: 1599-1613, 1990
Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE: Calcium movements in relation to heart function. Basic Res Cardiol 77: 117-139, 1982
Dhalla NS, Wang X, Beamish RE: Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol 1: 7-20, 1996
Dhalla NS, Shao Q, Panagia V: Remodeling of cardiac membranes during the development of congestive heart failure. Heart Failure Rev 2: 261-272, 1998
Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK: Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81: III-21-III-32, 1990
Arai M, Matsui H, Periasamy M: Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555-564, 1994
de la Bastie D, Levitsky D, Rappaport L, Mercadier JJ, Marotte F, Wisnewsky C, Brovkovich V, Schwartz K, Lompre AM: Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 66: 554-564, 1990
Schwinger RH, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, Erdmann E: Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995
Mercadier JJ, Lompre AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, Allen PD, Komajda M, Schwartz K: Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during endstage heart failure. J Clin Invest 85: 305-309, 1990
Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995
Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H: Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442, 1994
Dhalla NS, Afzal N, Beamish RE, Naimark B, Takeda N, Nagano M: Pathophysiology of cardiac dysfunction in congestive heart failure. Can J Cardiol 9: 873-887, 1993
Litwin SE, Morgan JP: Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res 71: 797-807, 1992
Afzal N, Dhalla NS: Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol Heart Circ Physiol 262: H868-H874, 1992
Afzal N, Dhalla NS: Sarcoplasmic reticular Ca2+ pump ATPase activity in congestive heart failure due to myocardial infarction. Can J Cardiol 12: 1065-1073, 1996
Zarain-Herzberg A, Afzal N, Elimban V, Dhalla NS: Decreased expression of cardiac sarcoplasmic reticulum Ca2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 163/164: 285-290, 1996
Iijima K, Geshi E, Nomizo A, Arata Y, Katagiri T: Alterations in sarcoplasmic reticulum and angiotensin II type 1 receptor gene expression after myocardial infarction in rats. Jpn Circ J 62: 449-454, 1998
Zhang XQ, Ng YC, Moore RL, Musch TI, Cheung JY: In situ SR function in postinfarction myocytes. J Appl Physiol 87: 2143-2150, 1999
Anand IS, Liu D, Chugh SS, Prahash AJ, Gupta S, John R, Popescu F, Chandrashekhar Y: Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 96: 3974-3984, 1997
Gupta S, Prahash AJ, Anand IS: Myocyte contractile function is intact in the post-infarct remodeled rat heart despite molecular alterations. Cardiovasc Res 48: 77-88, 2000
Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM: Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol 30: 1615-1630, 1998
Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH: Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodelling post-myocardial infarction ventricle. J Cardiovasc Pharmacol 33: 433-439, 1999
Omura T, Yoshiyama M, Takeuchi K, Hanatani A, Kim S, Yoshida K, Izumi Y, Iwao H, Yoshikawa J: Differences in time course of myocardial mRNA expression in non-infarcted myocardium after myocardial infarction. Basic Res Cardiol 95: 316-323, 2000
Yonekura K, Eto Y, Yokoyama I, Matsumoto A, Sugiura S, Momomura S, Kirimoto T, Hayashi Y, Omata M, Aoyagi T: Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction. Basic Res Cardiol 95: 343-348, 2000
Zhang LQ, Zhang XQ, Ng YC, Rothblum LI, Musch TI, Moore RL, Cheung JY: Sprint training normalizes Ca2+ transients and SR function in postinfarction rat myocytes. J Appl Physiol 89: 38-46, 2000
Ojamaa K, Kenessey A, Shenoy R, Klein I: Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 279: E1319-E1324, 2000
Pennock GD, Spooner PH, Summers CE, Litwin SE: Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3,5-diiodothyropropionic acid (DITPA). J Mol Cell Cardiol 32: 1939-1953, 2000
Yamaguchi F, Sanbe A, Takeo S: Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction. Br J Pharmacol 123: 326-334, 1998
Yoshiyama M, Takeuchi K, Hanatani A, Shimada T, Takemoto Y, Shimizu N, Omura T, Kim S, Iwao H, Yoshikawa J: Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression. Cardiovasc Drugs Ther 12: 57-70, 1998
Hanatani A, Yoshiyama M, Takeuchi K, Kim S, Nakayama K, Omura T, Iwao H, Yoshikawa J: Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats. Jpn J Pharmacol 78: 45-54, 1998
Pfeffer JM, Pfeffer MA, Braunwald E: Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation 75: I149-I155, 1987
Shao Q, Ren B, Zarain-Herzberg A, Ganguly PK, Dhalla NS: Captopril treatment improves the sarcoplasmic reticular Ca2+ transport in heart failure due to myocardial infarction. J Mol Cell Cardiol 31: 1663-1672, 1999
Litwin SE, Morgan JP: Effects of stimulation frequency on calcium transients in noninfarcted myocardium: Modulation by chronic captopril treatment. J Card Fail 5: 224-235, 1999
Watanabe M, Kawaguchi H, Onozuka H, Mikami T, Urasawa K, Okamoto H, Watanabe S, Abe K, Kitabatake A: Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts. J Cardiovasc Pharmacol 32: 248-259, 1998
Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, Iwao H: Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103: 148-154, 2001
Khaper N, Singal PK: Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 37: 1461-1466, 2001
Dixon IM, Lee SL, Dhalla NS: Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 66: 782-788, 1990
Wang J, Liu X, Ren B, Rupp H, Takeda N, Dhalla NS: Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction. J Mol Cell Cardiol 34: 847-857, 2002
Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E: Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
Wang J, Liu X, Sentex E, Takeda N, Dhalla NS: Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 2003 (in press)
Capasso JM, Li P, Anversa P: Cytosolic calcium transients in myocytes isolated from rats with ischemic heart failure. Am J Physiol Heart Circ Physiol 265: H1953-H1964, 1993
Sethi R, Elimban V, Chapman D, Dixon IM, Dhalla NS: Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 30: 2153-2163, 1998
Li P, Park C, Micheletti R, Li B, Cheng W, Sonnenblick EH, Anversa P, Bianchi G: Myocyte performance during evolution of myocardial infarction in rats: Effects of propionyl-L-carnitine. Am J Physiol Heart Circ Physiol 268: H1702-H1713, 1995
Cheung JY, Musch TI, Misawa H, Semanchick A, Elensky M, Yelamarty RV, Moore RL: Impaired cardiac function in rats with healed myocardial infarction: Cellular vs. myocardial mechanisms. Am J Physiol Cell Physiol 266: C29-C36, 1994
Holt E, Tonnessen T, Lunde PK, Semb SO, Wasserstrom JA, Sejersted OM, Christensen G: Mechanisms of cardiomyocyte dysfunction in heart failure following myocardial infarction in rats. J Mol Cell Cardiol 30: 1581-1593, 1998
Brittsan AG, Carr AN, Schmidt AG, Kranias EG: Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem 275: 12129-12135, 2000
Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ: Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97: 793-798, 2000
Anthonio RL, van Veldhuisen DJ, van Gilst WH: Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both? J Cardiovasc Pharmacol 32: S1-S8, 1998
Mulder P, Devaux B, Richard V, Henry JP, Wimart MC, Thibout E, Mace B, Thuillez C: Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling. Circulation 95: 1314-1319, 1997
Jain P, Korlipara G, Mallavarapu C, Sikand V, Lillis O, Cohn PF: Effects of captopril therapy after late reperfusion on left ventricular remodeling after experimental myocardial infarction. Am Heart J 127: 756-763, 1994
Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T: Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 23: 411-418, 1994
Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M, Modesti PA: Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 88: 961-968, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guo, X., Chapman, D. & Dhalla, N.S. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan. Mol Cell Biochem 254, 163–172 (2003). https://doi.org/10.1023/A:1027321130997
Issue Date:
DOI: https://doi.org/10.1023/A:1027321130997